NHS set to save £150 million by switching to new versions of most costly drug

Health chief Simon Stevens has today asked NHS hospitals to ensure they are ready to realise savings of up to £150 million a year to reinvest in frontline care after the patent on the NHS’s most costly drug ends this week. Adalimumab is the single medicine on which hospitals spend the most, at a cost […]